Age Predicts Functional Outcome in Acute Stroke Patients with rt-PA Treatment
Table 2
Clinical characters of acute stroke patients with intravenous recombinant tissue-type plasminogen activator (rt-PA) treatment by Barthel index less than or equal to 80 or more at 3 months after treatment.
Variables
Barthel index ≤80
Barthel index >80
value
Median age
71 (48–87)
65 (27–78)
0.030
Male gender,
18 (66.67)
22 (53.67)
0.286
Median GCS
15 (11–15)
15 (9–15)
0.540
Diabetes,
12 (44.44)
13 (31.71)
0.286
Hypertension,
16 (59.26)
19 (46.34)
0.297
Dyslipidemia,
5 (18.52)
11 (26.83)
0.429
Atrial fibrillation,
8 (29.63)
8 (19.51)
0.336
Smoking,
18 (66.67)
20 (48.78)
0.146
Median NIHSS
8 (4–24)
9 (1–19)
0.377
Median SBP mmHg
137 (90–193)
137 (90–190)
0.380
Median DBP mmHg
78 (60–109)
80 (50–120)
0.374
Median glucose, mg/dL
90 (15–240)
120 (15–240)
0.195
Note. Data presented as median (range) or number (%); GCS: Glasgow Coma Scale; NIHSS: The National Institutes of Health Stroke Scale; SBP: systolic blood pressure; DBP: diastolic blood pressure.
